Patents by Inventor Adam Michael GUSS

Adam Michael GUSS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240026393
    Abstract: Muconic acid is a molecule that can be converted into direct replacement chemicals for incumbent petrochemicals and performance-advantaged bioproducts. Disclosed herein are Pseudomonas putida KT2440 that are engineered to convert glucose and xylose, the primary carbohydrates in lignocellulosic hydrolysates, to muconic acid using a model-guided strategy to maximize the theoretical yield. Using adaptive laboratory evolution (ALE) and metabolic engineering in a strain engineered to express the D-xylose isomerase pathway, we demonstrated that mutations in the heterologous D-xylose:H+ symporter (XylE), increased expression of a major facilitator superfamily transporter (PP_2569), and overexpression of aroB encoding the native 3-dehydroquinate synthase, enable efficient muconic acid production from glucose and xylose simultaneously. Using the rationally engineered strain, we produced 33.7 g/L muconate at 0.18 g/L/h and a 46% molar yield (92% of the maximum theoretical yield).
    Type: Application
    Filed: March 20, 2023
    Publication date: January 25, 2024
    Inventors: Chen LING, Christopher W. JOHNSON, Gregg Tyler BECKHAM, George Lee PEABODY, V, Adam Michael GUSS
  • Patent number: 11518975
    Abstract: The present disclosure relates to a non-naturally occurring microorganism that includes an endogenous genetic deletion that eliminates the expression of at least a pyruvate kinase, where the genetically modified prokaryotic microorganism is capable of producing 3-deoxy-D-arabino-heptulosonate-7-phosphate.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: December 6, 2022
    Assignees: Alliance for Sustainable Energy, LLC, UT-Battelle, LLC, TRIAD National Security, LLC
    Inventors: Christopher W. Johnson, Peter Corbin St. John, Gregg Tyler Beckham, Joshua Ryan Elmore, Adam Michael Guss, Davinia Salvachua Rodriguez, Gayle Joann Bentley, George Lee Peabody, V, Taraka Dale, Ramesh K. Jha, Niju Narayanan
  • Publication number: 20210285019
    Abstract: Disclosed herein are methods and compositions for catalytic glycolysis to deconstruct PET to bis(2-hydroxyethyl) terephthalate (BHET). For BHET conversion to terephthalate and ethylene glycol, we engineer Pseudomonas putida KT2440 with PETase and MHETase enzymes from Ideonella sakaiensis. We further engineer P. putida to convert terephthalate to a performance-advantaged bioproduct, ?-ketoadipic acid, and for improved utilization of ethylene glycol, a byproduct of BHET catabolism. In a bioreactor, we produce 15.1±0.6 g/L of ?-ketoadipic acid (?KA) from BHET at 76±3% molar yield. Lastly, we demonstrate conversion of catalytically depolymerized PET to ?KA. Overall, this work highlights the potential of tandem catalytic deconstruction and biological conversion as a means to upcycle waste PET.
    Type: Application
    Filed: March 10, 2021
    Publication date: September 16, 2021
    Inventors: Gregg Tyler BECKHAM, Thelhawadigedara Lahiru Niroshan JAYAKODY, Adam Michael GUSS, Thomas David MAND, Christopher W. JOHNSON, Isabel PARDO MENDOZA, Allison Jean ZIMONT WERNER
  • Publication number: 20210180007
    Abstract: Disclosed herein are engineered P. putida KT2440 co-expressing PETase and MHETase enzymes that selectively degrades PET into monomers, ethylene glycol and terephthalate (TPA). In another embodiment, disclosed herein are methods for making and using a highly efficient EG metabolizing P. putida KT2440 strain. Given that native P. putida does not have a TPA metabolic pathway, nor the proteins to transport TPA into the cell, the next metabolic engineering challenge for developing synthetic P. putida strain to plastic upcycling was enabling TPA catabolism in P. putida KT2440. TPA transporters and catabolic pathway have been characterized in several microorganisms including Comamonas sp. strain E6 and Rhodococcus jostii RHA1.
    Type: Application
    Filed: May 15, 2019
    Publication date: June 17, 2021
    Inventors: Gregg Tyler BECKHAM, Thelhawadigedara Lahiru Niroshan JAYAKODY, Adam Michael GUSS, Thomas David MAND, Christopher W. JOHNSON, Isabel PARDO MENDOZA
  • Publication number: 20190367865
    Abstract: The present disclosure relates to a non-naturally occurring microorganism that includes an endogenous genetic deletion that eliminates the expression of at least a pyruvate kinase, where the genetically modified prokaryotic microorganism is capable of producing 3-deoxy-D-arabino-heptulosonate-7-phosphate.
    Type: Application
    Filed: April 30, 2019
    Publication date: December 5, 2019
    Inventors: Christopher W. JOHNSON, Peter Corbin ST. JOHN, Gregg Tyler BECKHAM, Joshua Ryan ELMORE, Adam Michael GUSS, Davinia Salvachua RODRIGUEZ, Gayle Joann BENTLEY, George Lee PEABODY V